Hangzhou DAC Biotech Co., Ltd

company

About

Hangzhou DAC Biotech Co., Ltd focuses on developing conjugate of monoclonal antibody and small molecular cytotoxic drugs.

  • 101 - 250

Details

Last Funding Type
Seed
Last Funding Money Raised
¥1M
Industries
Biotechnology,Health Care,Medical
Founded date
Dec 31, 2012
Number Of Employee
101 - 250
Operating Status
Active

Funding Rounds

Number of Funding Rounds
Total Funding Amount
4
¥1.07B
Hangzhou DAC Biotech Co., Ltd has raised a total of ¥1.07B in funding over 2 rounds. Their latest funding was raised on May 12, 2021 from a Series C round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
May 12, 2021 Series C ¥1B 2 Detail
Jan 12, 2018 Series B ¥20M 1 Detail
May 26, 2017 Series A ¥50M 1 Huahai Yaoye Detail
Oct 22, 2013 Seed ¥1M 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
5
Hangzhou DAC Biotech Co., Ltd is funded by 5 investors. Huahai Yaoye and Kwai Hung Group are the most recent investors.
Investor Name Lead Investor Funding Round
Huahai Yaoye Yes Series A
Kwai Hung Group Series C
Tigeryeah Capital Series C
Jinyongxin Investment Management Series B
Jinji Yiyao Touzi Seed